Cargando…

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy

BACKGROUND: We have developed a recombinant B cell epitope-based vaccine (BM32) for allergen-specific immunotherapy (AIT) of grass pollen allergy. The vaccine contains recombinant fusion proteins consisting of allergen-derived peptides and the hepatitis B surface protein domain preS as immunological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zieglmayer, Petra, Focke-Tejkl, Margarete, Schmutz, René, Lemell, Patrick, Zieglmayer, René, Weber, Milena, Kiss, Renata, Blatt, Katharina, Valent, Peter, Stolz, Frank, Huber, Hans, Neubauer, Angela, Knoll, Anette, Horak, Friedrich, Henning, Rainer, Valenta, Rudolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049999/ https://www.ncbi.nlm.nih.gov/pubmed/27650868 http://dx.doi.org/10.1016/j.ebiom.2016.08.022

Ejemplares similares

Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32
por: Tulaeva, Inna, et al.
Publicado: (2020)

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
por: Focke-Tejkl, Margarete, et al.
Publicado: (2015)

Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines
por: Weber, Milena, et al.
Publicado: (2017)

IgE Epitopes of the House Dust Mite Allergen Der p 7 Are Mainly Discontinuous and Conformational
por: Curin, Mirela, et al.
Publicado: (2021)

Peripheral Erythrocytes Decrease upon Specific Respiratory Challenge with Grass Pollen Allergen in Sensitized Mice and in Human Subjects
por: Jordakieva, Galateja, et al.
Publicado: (2014)

Allergen challenge tests in allergen immunotherapy: State of the art
por: Zieglmayer, Petra, et al.
Publicado: (2023)

Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study
por: Roth-Walter, Franziska, et al.
Publicado: (2018)

Detection of genuine grass pollen sensitization in children by skin testing with a recombinant grass pollen hybrid
por: Douladiris, Nikolaos, et al.
Publicado: (2018)

Fast effectiveness of a solubilized low‐dose budesonide nasal spray in allergic rhinitis
por: Zieglmayer, Petra, et al.
Publicado: (2020)

Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5
por: Levin, M, et al.
Publicado: (2014)

Epitope specificity determines cross‐protection of a SIT‐induced IgG(4) antibody
por: Gadermaier, E., et al.
Publicado: (2015)

A B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help
por: Narayanan, Meena, et al.
Publicado: (2017)

Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen
por: Resch, Yvonne, et al.
Publicado: (2016)

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32
por: Niederberger, Verena, et al.
Publicado: (2018)

Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection
por: Cornelius, Carolin, et al.
Publicado: (2016)

Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
por: Jordakieva, Galateja, et al.
Publicado: (2017)

Expression and characterization of recombinant Par j 1 and Par j 2 resembling the allergenic epitopes of Parietaria judaica pollen
por: Dorofeeva, Yulia, et al.
Publicado: (2019)

Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Expression in Escherichia coli and Purification of Folded rDer p 20, the Arginine Kinase From Dermatophagoides pteronyssinus: A Possible Biomarker for Allergic Asthma
por: Sarzsinszky, Eszter, et al.
Publicado: (2020)

Effects of Nasal Corticosteroids on Boosts of Systemic Allergen-Specific IgE Production Induced by Nasal Allergen Exposure
por: Egger, Cornelia, et al.
Publicado: (2015)

Allergen Microarray Indicates Pooideae Sensitization in Brazilian Grass Pollen Allergic Patients
por: Moreira, Priscila Ferreira de Sousa, et al.
Publicado: (2015)

Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy
por: Linhart, B, et al.
Publicado: (2014)

Possible effect of landscape design on IgE recognition profiles of two generations revealed with micro‐arrayed allergens
por: Garib, V., et al.
Publicado: (2017)

Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy
por: Freidl, Raphaela, et al.
Publicado: (2016)

A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens
por: Huang, Huey‐Jy, et al.
Publicado: (2019)

Pru p 3, a marker allergen for lipid transfer protein sensitization also in Central Europe
por: Mothes‐Luksch, N., et al.
Publicado: (2017)

Linear Epitope Binding Patterns of Grass Pollen-Specific Antibodies in Allergy and in Response to Allergen-Specific Immunotherapy
por: Thörnqvist, Linnea, et al.
Publicado: (2022)

Antibodies induced by immunization with a hypoallergenic mutant of the major fish allergen Cyp c 1 inhibit allergic symptoms in a mouse model of fish allergy
por: Gstoettner, AC, et al.
Publicado: (2013)

Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms
por: Campana, Raffaela, et al.
Publicado: (2018)

Two grass pollen tablets commercially available for allergy immunotherapy display different IgE epitope repertoires
por: Batard, Thierry, et al.
Publicado: (2019)

Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study
por: Shah-Hosseini, Kija, et al.
Publicado: (2017)

Treatment of grass pollen allergy: focus on a standardized grass allergen extract – Grazax(®)
por: Calderón, Moisés, et al.
Publicado: (2008)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?
por: Valenta, Rudolf, et al.
Publicado: (2018)

BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils
por: Smiljkovic, D., et al.
Publicado: (2017)

From Allergen Molecules to Molecular Immunotherapy of Nut Allergy: A Hard Nut to Crack
por: Fuhrmann, Verena, et al.
Publicado: (2021)

Grass pollen allergy in children and adolescents-symptoms, health related quality of life and the value of pollen prognosis
por: Kiotseridis, Hampus, et al.
Publicado: (2013)

Assessment of Google Trends terms reporting allergies and the grass pollen season in Ukraine
por: Kaidashev, Igor, et al.
Publicado: (2020)

Are Markers of Allergic Inflammation in Grass Pollen Allergy Influenced by H1 Antihistamines?
por: Bocsan, Ioana Corina, et al.
Publicado: (2021)

Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response
por: Borochova, Kristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h8q0a6bo4040ac8loeo06posqs